Endocyte Inc. (ECYT) is Trading Higher on Unusual Volume for December 21

Equities Staff |

Endocyte Inc. (ECYT) experienced unusually high volume on Dec. 21, as the stock gained 1.22% to a closing price of $4.14. The stock saw 469,026 shares trade hands over the course of the day on 1,732 trades. Given that the stock’s average daily volume over the last month has been 228,044 shares a day, this represents a pretty substantial spike over the norm.

Endocyte Inc. has a P/B ratio of 0.97. The stock has traded between $6.76 and $3.83 over the last 52-weeks, its 50-day SMA is now $4.69, and its 200-day SMA $5.40.

Endocyte Inc is a biopharmaceutical company. The Company is engaged in developing targeted therapies for the treatment of cancer and inflammatory diseases.

Headquartered in West Lafayette, IN, Endocyte Inc. has 81 employees and is currently under the leadership of CEO P. Ellis.

For a complete fundamental analysis analysis of Endocyte Inc., check out Equities.com’s Stock Valuation Analysis report for ECYT. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

THE IMPORTANCE OF THE RUSSELL 3000

The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Winston Gold Mining Corp.

Winston Gold Mining Corp is a mineral exploration and development company. The Company is engaged in acquiring, exploring, developing, and operating mining properties.

Private Markets

Ozobot by Evollve Inc

Ozobot is a world leader in compact super intelligent robots that entertain and educate through fun interactive gaming.

WayBetter

The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…